Literature DB >> 9422897

Emergence times from xenon anaesthesia are independent of the duration of anaesthesia.

T Goto1, H Saito, Y Nakata, S Uezono, F Ichinose, S Morita.   

Abstract

Xenon (MAC = 71%) has an extremely low blood:gas partition coefficient (0.14). Therefore, we predicted that the rate of emergence from xenon anaesthesia would not be affected greatly by duration of anaesthesia. We studied 54 ASA I-II patients undergoing lower abdominal surgery who received equal MAC anaesthesia with 60% xenon, 60% nitrous oxide with 0.5% isoflurane or 60% nitrous oxide with 0.7% sevoflurane (n = 18 per group), each supplemented with extradural mepivacaine anaesthesia. Duration of anaesthesia was 58-380 min. At the end of operation, all inhalation anaesthetics were discontinued and patients were allowed to wake up while breathing oxygen spontaneously. A blinded investigator recorded the time until patients opened their eyes on command (T1), were judged ready for tracheal extubation (T2), could correctly state their name, date of birth and name of the hospital (T3), and could count backwards from 10 to 1 in less than 15 s (T4). Emergence times after xenon and nitrous oxide-sevoflurane anaesthesia did not correlate with duration of anaesthesia, whereas those from nitrous oxide-isoflurane had positive correlations. Mean emergence times from xenon anaesthesia were: T1, 3.3 (SD 1.0) min; T2, 3.6 (1.0) min; T3, 5.0 (1.1) min; and T4, 6.2 (1.7) min. These values were approximately 50% of those after nitrous oxide-sevoflurane anaesthesia (T1, 5.6 (1.4) min; T4, 10.5 (2.0) min). We conclude that xenon provided fast emergence from anaesthesia, regardless of the duration of anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422897     DOI: 10.1093/bja/79.5.595

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

1.  Xenon washout during in-vitro extracorporeal circulation using different oxygenators.

Authors:  Uwe Schirmer; Helmut Reinelt; Matthias Erber; Michael Schmidt; Thomas Marx
Journal:  J Clin Monit Comput       Date:  2002 Apr-May       Impact factor: 2.502

Review 2.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

3.  Monitoring xenon in the breathing circuit with a thermal conductivity sensor. Comparison with a mass spectrometer and implications on monitoring other gases.

Authors:  Martin Luginbühl; Rolf Lauber; Peter Feigenwinter; Alex M Zbinden
Journal:  J Clin Monit Comput       Date:  2002-01       Impact factor: 2.502

4.  Inhalational Gases for Neuroprotection in Traumatic Brain Injury.

Authors:  Samuel S Shin; Misun Hwang; Ramon Diaz-Arrastia; Todd J Kilbaugh
Journal:  J Neurotrauma       Date:  2021-06-08       Impact factor: 4.869

5.  Xenon pressure dependence on the synchronized burst inhibition of rat cortical neuronal network cultured on multi-electrode arrays.

Authors:  Tsutomu Uchida; Koichiro Shimada; Ryutaro Tanabe; Tatsuya Kubota; Daisuke Ito; Kenji Yamazaki; Kazutoshi Gohara
Journal:  IBRO Rep       Date:  2017-09-08

Review 6.  The Role of Anesthetic Selection in Perioperative Bleeding.

Authors:  Koichi Yuki; James A DiNardo; Sophia Koutsogiannaki
Journal:  Biomed Res Int       Date:  2021-05-07       Impact factor: 3.411

Review 7.  Nitrous oxide-based versus nitrous oxide-free general anaesthesia and accidental awareness during general anaesthesia in surgical patients.

Authors:  Juliet Hounsome; Amanda Nicholson; Janette Greenhalgh; Tim M Cook; Andrew F Smith; Sharon R Lewis
Journal:  Cochrane Database Syst Rev       Date:  2016-08-10

8.  Nausea and Vomiting following Balanced Xenon Anesthesia Compared to Sevoflurane: A Post-Hoc Explorative Analysis of a Randomized Controlled Trial.

Authors:  Astrid V Fahlenkamp; Christian Stoppe; Jan Cremer; Ingeborg A Biener; Dirk Peters; Ricarda Leuchter; Albrecht Eisert; Christian C Apfel; Rolf Rossaint; Mark Coburn
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.